ArticleProceedings of the National Academy of Sciences of the United States of America2014

Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy.

Andrew Hiatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.